Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 181.1

(0.39%)

Net Income Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual net income in 2023 was -42 Million ILS , down -188.41% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly net income in 2024 Q2 was 13.25 Million ILS , up 10.42% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported an annual net income of 47.51 Million ILS in 2022, up 12.27% from previous year.
Novolog (Pharm-Up 1966) Ltd reported an annual net income of 42.31 Million ILS in 2021, up 5.62% from previous year.
Novolog (Pharm-Up 1966) Ltd reported a quarterly net income of 13.25 Million ILS for 2024 Q2, up 10.42% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported a quarterly net income of -42 Million ILS for 2023 FY, down -188.41% from previous quarter.

Annual Net Income Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2013)

Historical Annual Net Income of Novolog (Pharm-Up 1966) Ltd (2023 - 2013)

Year	Net Income	Net Income Growth
2023	-42 Million ILS	-188.41%
2022	47.51 Million ILS	12.27%
2021	42.31 Million ILS	5.62%
2020	40.06 Million ILS	295.26%
2019	10.13 Million ILS	-53.63%
2018	21.86 Million ILS	-2.81%
2017	22.49 Million ILS	-22.76%
2016	29.12 Million ILS	15.3%
2015	25.25 Million ILS	7.3%
2014	23.53 Million ILS	59.18%
2013	14.78 Million ILS	0.0%

Year	Net Income	Net Income Growth
2024 Q1	12 Million ILS	127.57%
2024 Q2	13.25 Million ILS	10.42%
2023 FY	-42 Million ILS	-188.41%
2023 Q1	-8.76 Million ILS	-164.26%
2023 Q4	-43.52 Million ILS	-13210.84%
2023 Q2	11.22 Million ILS	228.03%
2023 Q3	332 Thousand ILS	-97.04%
2022 Q1	12.04 Million ILS	30.97%
2022 FY	47.51 Million ILS	12.27%
2022 Q4	13.64 Million ILS	34.72%
2022 Q3	10.12 Million ILS	-15.57%
2022 Q2	11.99 Million ILS	-0.38%
2021 Q3	10.14 Million ILS	0.28%
2021 FY	42.31 Million ILS	5.62%
2021 Q2	10.11 Million ILS	-25.11%
2021 Q1	13.51 Million ILS	72.22%
2021 Q4	9.19 Million ILS	-9.4%
2020 Q3	9.7 Million ILS	6.39%
2020 Q1	13.4 Million ILS	193.84%
2020 Q2	9.11 Million ILS	-31.97%
2020 FY	40.06 Million ILS	295.26%
2020 Q4	7.84 Million ILS	-19.12%
2019 Q2	3.46 Million ILS	-40.44%
2019 FY	10.13 Million ILS	-53.63%
2019 Q4	4.56 Million ILS	223.04%
2019 Q3	-3.7 Million ILS	-206.98%
2019 Q1	5.81 Million ILS	26.92%
2018 Q1	6.23 Million ILS	37.86%
2018 FY	21.86 Million ILS	-2.81%
2018 Q4	4.58 Million ILS	-10.21%
2018 Q3	5.1 Million ILS	-14.09%
2018 Q2	5.94 Million ILS	-4.62%
2017 Q2	5.72 Million ILS	-8.34%
2017 Q3	5.99 Million ILS	4.73%
2017 FY	22.49 Million ILS	-22.76%
2017 Q4	4.51 Million ILS	-24.66%
2017 Q1	6.24 Million ILS	37.14%
2016 Q1	8.26 Million ILS	135.78%
2016 Q4	4.55 Million ILS	-35.39%
2016 FY	29.12 Million ILS	15.3%
2016 Q3	7.05 Million ILS	-23.77%
2016 Q2	9.25 Million ILS	11.93%
2015 FY	25.25 Million ILS	7.3%
2015 Q3	4.64 Million ILS	0.0%
2015 Q4	3.5 Million ILS	-24.48%
2014 FY	23.53 Million ILS	59.18%
2013 FY	14.78 Million ILS	0.0%

Peer Net Income Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Net Income	Net Income Difference